Literature DB >> 25574027

Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation.

Marta Biagioli1, Francesco Ferrari2, Eric M Mendenhall3, Yijing Zhang4, Serkan Erdin4, Ravi Vijayvargia1, Sonia M Vallabh4, Nicole Solomos4, Poornima Manavalan4, Ashok Ragavendran4, Fatih Ozsolak5, Jong Min Lee1, Michael E Talkowski6, James F Gusella7, Marcy E Macdonald8, Peter J Park9, Ihn Sik Seong10.   

Abstract

The CAG repeat expansion in the Huntington's disease gene HTT extends a polyglutamine tract in mutant huntingtin that enhances its ability to facilitate polycomb repressive complex 2 (PRC2). To gain insight into this dominant gain of function, we mapped histone modifications genome-wide across an isogenic panel of mouse embryonic stem cell (ESC) and neuronal progenitor cell (NPC) lines, comparing the effects of Htt null and different size Htt CAG mutations. We found that Htt is required in ESC for the proper deposition of histone H3K27me3 at a subset of 'bivalent' loci but in NPC it is needed at 'bivalent' loci for both the proper maintenance and the appropriate removal of this mark. In contrast, Htt CAG size, though changing histone H3K27me3, is prominently associated with altered histone H3K4me3 at 'active' loci. The sets of ESC and NPC genes with altered histone marks delineated by the lack of huntingtin or the presence of mutant huntingtin, though distinct, are enriched in similar pathways with apoptosis specifically highlighted for the CAG mutation. Thus, the manner by which huntingtin function facilitates PRC2 may afford mutant huntingtin with multiple opportunities to impinge upon the broader machinery that orchestrates developmentally appropriate chromatin status.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25574027      PMCID: PMC4383859          DOI: 10.1093/hmg/ddv006

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

1.  Genomic maps and comparative analysis of histone modifications in human and mouse.

Authors:  Bradley E Bernstein; Michael Kamal; Kerstin Lindblad-Toh; Stefan Bekiranov; Dione K Bailey; Dana J Huebert; Scott McMahon; Elinor K Karlsson; Edward J Kulbokas; Thomas R Gingeras; Stuart L Schreiber; Eric S Lander
Journal:  Cell       Date:  2005-01-28       Impact factor: 41.582

2.  Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells.

Authors:  Miriam Bibel; Jens Richter; Emmanuel Lacroix; Yves-Alain Barde
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 3.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

4.  UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.

Authors:  Karl Agger; Paul A C Cloos; Jesper Christensen; Diego Pasini; Simon Rose; Juri Rappsilber; Irina Issaeva; Eli Canaani; Anna Elisabetta Salcini; Kristian Helin
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

Review 5.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

Authors:  Paul A C Cloos; Jesper Christensen; Karl Agger; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

Review 6.  Huntington's disease: seeing the pathogenic process through a genetic lens.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Trends Biochem Sci       Date:  2006-07-10       Impact factor: 13.807

7.  Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein.

Authors:  Min Gyu Lee; Jessica Norman; Ali Shilatifard; Ramin Shiekhattar
Journal:  Cell       Date:  2007-02-22       Impact factor: 41.582

8.  Normal electrical properties of hippocampal neurons modelling early Huntington disease pathogenesis.

Authors:  Peggy Shelbourne; Edward Coote; Selma Dadak; Stuart R Cobb
Journal:  Brain Res       Date:  2007-01-09       Impact factor: 3.252

9.  Genome-wide maps of chromatin state in pluripotent and lineage-committed cells.

Authors:  Tarjei S Mikkelsen; Manching Ku; David B Jaffe; Biju Issac; Erez Lieberman; Georgia Giannoukos; Pablo Alvarez; William Brockman; Tae-Kyung Kim; Richard P Koche; William Lee; Eric Mendenhall; Aisling O'Donovan; Aviva Presser; Carsten Russ; Xiaohui Xie; Alexander Meissner; Marius Wernig; Rudolf Jaenisch; Chad Nusbaum; Eric S Lander; Bradley E Bernstein
Journal:  Nature       Date:  2007-07-01       Impact factor: 49.962

10.  Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo.

Authors:  Juliana M Woda; Teresa Calzonetti; Paige Hilditch-Maguire; Mabel P Duyao; Ronald A Conlon; Marcy E MacDonald
Journal:  BMC Dev Biol       Date:  2005-08-18       Impact factor: 1.978

View more
  25 in total

1.  A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine.

Authors:  Andrew M Stern; Mark E Schurdak; Ivet Bahar; Jeremy M Berg; D Lansing Taylor
Journal:  J Biomol Screen       Date:  2016-03-08

2.  Fighting the Huntington's Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies.

Authors:  Claudia Riccardi; Federica D'Aria; Filomena Anna Digilio; Maria Rosaria Carillo; Jussara Amato; Dominga Fasano; Laura De Rosa; Simona Paladino; Mariarosa Anna Beatrice Melone; Daniela Montesarchio; Concetta Giancola
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 3.  Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.

Authors:  Julia Kaye; Terry Reisine; Steven Finkbeiner
Journal:  Fac Rev       Date:  2022-06-28

Review 4.  Histone Methylation Regulation in Neurodegenerative Disorders.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 5.  Epigenetic regulation in Huntington's disease.

Authors:  Jae Wook Hyeon; Albert H Kim; Hiroko Yano
Journal:  Neurochem Int       Date:  2021-05-24       Impact factor: 4.297

Review 6.  Contribution of Neuroepigenetics to Huntington's Disease.

Authors:  Laetitia Francelle; Caroline Lotz; Tiago Outeiro; Emmanuel Brouillet; Karine Merienne
Journal:  Front Hum Neurosci       Date:  2017-01-30       Impact factor: 3.169

7.  Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels.

Authors:  Steve Horvath; Peter Langfelder; Seung Kwak; Jeff Aaronson; Jim Rosinski; Thomas F Vogt; Marika Eszes; Richard L M Faull; Maurice A Curtis; Henry J Waldvogel; Oi-Wa Choi; Spencer Tung; Harry V Vinters; Giovanni Coppola; X William Yang
Journal:  Aging (Albany NY)       Date:  2016-07       Impact factor: 5.682

8.  Polycomb repressive complex 1 provides a molecular explanation for repeat copy number dependency in FSHD muscular dystrophy.

Authors:  Valentina Casa; Valeria Runfola; Stefano Micheloni; Arif Aziz; F Jeffrey Dilworth; Davide Gabellini
Journal:  Hum Mol Genet       Date:  2017-02-15       Impact factor: 6.150

9.  The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease.

Authors:  Xianjun Dong; Junko Tsuji; Adam Labadorf; Panos Roussos; Jiang-Fan Chen; Richard H Myers; Schahram Akbarian; Zhiping Weng
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

10.  Huntington's Disease as Neurodevelopmental Disorder: Altered Chromatin Regulation, Coding, and Non-Coding RNA Transcription.

Authors:  Emanuela Kerschbamer; Marta Biagioli
Journal:  Front Neurosci       Date:  2016-01-13       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.